Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Multiple Sclerosis

Free Subscription Articles published in J Neuroimmunol Retrieve available abstracts of 124 articles: HTML format Text format

Single Articles

February 2010
1. DOBSON R , Miller RF, Palmer HE, Feldmann M, et al
   Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. KARUSSIS D , Teitelbaum D, Sicsic C, Brenner T, et al
   Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. PIAZZA F , Difrancesco JC, Fusco ML, Corti D, et al
   Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
4. BRYNEDAL B , Wojcik J, Esposito F, Debailleul V, et al
   MGAT5 alters the severity of multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. BERGAMASCHI L , Ban M, Leone MA, Sawcer SJ, et al
   No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. ALDINUCCI A , Biagioli T, Manuelli C, Repice AM, et al
   Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP.
   J Neuroimmunol. 2010;218.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. JURYNCZYK M , Selmaj K
   Notch: a new player in MS mechanisms.
   J Neuroimmunol. 2010;218.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
8. WU JS , James I, Qiu W, Castley A, et al
   HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
   J Neuroimmunol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. NAMDAR A , Nikbin B, Ghabaee M, Bayati A, et al
   Effect of IFN-ss therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): A preliminary study.
   J Neuroimmunol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. GANDHI R , Laroni A, Weiner HL
    Role of the innate immune system in the pathogenesis of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SAWAI S , Umemura H, Mori M, Satoh M, et al
    Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: Proteomic analysis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. YOKOTA SI , Chiba S, Furuyama H, Fujii N, et al
    Cerebrospinal fluids containing anti-HSP70 autoantibodies from multiple sclerosis patients augment HSP70-induced proinflammatory cytokine production in monocytic cells.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
13. BRETTSCHNEIDER J , Jaskowski TD, Tumani H, Abdul S, et al
    Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ZARIF YEGANEH M , Ghaffarpour M, Farhud DD, Karimlou M, et al
    Skew in the human caveolin 1 gene upstream purine complex homozygote haplotype compartment in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BERG-HANSEN P , Vandvik B, Fagerhol M, Holmoy T, et al
    Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
16. DEB C , Howe CL
    Functional characterization of mouse spinal cord infiltrating CD8+ lymphocytes.
    J Neuroimmunol. 2009;214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. AWAD A , Hemmer B, Hartung HP, Kieseier B, et al
    Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SMITH D
    Interferon-beta therapy for multiple sclerosis - Is the injection site the relevant action site?
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. PETERSEN T , Moller-Larsen A, Thiel S, Brudek T, et al
    Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. VANDENBARK AA , Huan J, Agotsch M, La Tocha D, et al
    Interferon-beta-1a treatment increases CD56(bright) natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SUNDSTROM P , Nystrom M, Ruuth K, Lundgren E, et al
    Antibodies to specific EBNA-1 domains and HLA DRB11501 interact as risk factors for multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
22. DRULOVIC J , Savic E, Pekmezovic T, Mesaros S, et al
    Expression of T(H)1 and T(H)17 cytokines and transcription factors in multiple sclerosis patients: Does baseline T-Bet mRNA predict the response to interferon-beta treatment?
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. TEGLA CA , Cudrici C, Rus V, Ito T, et al
    Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
    J Neuroimmunol. 2009;213.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. BLASKO E , Haskell CA, Leung S, Gualtieri G, et al
    Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
25. HAAS J , Korporal M, Balint B, Fritzsching B, et al
    Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. STUBGEN JP
    Recombinant interferon-beta therapy and neuromuscular disorders.
    J Neuroimmunol. 2009;212.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. CAMERON EM , Spencer S, Lazarini J, Harp CT, et al
    Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. FERNANDES KS , Brum DG, Sandrim VC, Guerreiro CT, et al
    Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MIROWSKA-GUZEL D , Gromadzka G, Czlonkowski A, Czlonkowska A, et al
    Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. VASCONCELOS CC , Fernandez O, Leyva L, Thuler LC, et al
    Does the DRB11501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. MOSSBERG N , Movitz C, Hellstrand K, Bergstrom T, et al
    Oxygen radical production in leukocytes and disease severity in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    June 2009
32. SCHNEIDER C , Schuetz G, Zollner TM
    Acute neuroinflammation in Lewis rats - A model for acute multiple sclerosis relapses.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. TANI T , Sakimura K, Tsujita M, Nakada T, et al
    Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica.
    J Neuroimmunol. 2009;211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. ROYAL W 3RD , Mia Y, Li H, Naunton K, et al
    Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. CAMINA-TATO M , Morcillo-Suarez C, Navarro A, Fernandez M, et al
    Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
36. LAPE NIXON M , Matud J, Yeh C, Prince HE, et al
    Evaluation of a multiplex bead-based screening assay for detection of binding antibodies to interferon-beta.
    J Neuroimmunol. 2009;210.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. HATCH MN , Schaumburg CS, Lane TE, Keirstead HS, et al
    Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. AARSKOG NK , Maroy T, Myhr KM, Vedeler CA, et al
    Antibodies against interferon-beta in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. IDIMAN E , Ozakbas S, Dogan Y, Kosehasanogullari G, et al
    The significance of oligoclonal bands in multiple sclerosis: Relevance of demographic and clinical features, and immunogenetic backgrounds.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ENEVOLD C , Oturai AB, Sorensen PS, Ryder LP, et al
    Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. KAUFFMAN MA , Villa AM
    Comment to Tumour necrosis factor alpha gene -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
42. KAISER CC , Shukla DK, Stebbins GT, Skias DD, et al
    A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. DE ANDRES C , Aristimuno C, Bartolome M, de Las Heras V, et al
    Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4(+) regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudina
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. VILLAR LM , Masterman T, Casanova B, Gomez-Rial J, et al
    CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. RAMAGOPALAN SV , Morrison KM, Para A, Handel A, et al
    Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. AZOULAY D , Mausner-Fainberg K, Urshansky N, Fahoum F, et al
    Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
47. PERERA D , Stankovich J, Butzkueven H, Taylor BV, et al
    Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. MAKAR TK , Bever CT, Singh IS, Royal W, et al
    Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
49. ANDREOLI V , Trecroci F, La Russa A, Valentino P, et al
    CASP-9: A susceptibility locus for multiple sclerosis in Italy.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. COMABELLA M , Fernandez-Arquero M, Rio J, Guinea A, et al
    HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
51. DE MASI R , Vergara D, Pasca S, Acierno R, et al
    PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: A pilot study on relation to clinical findings and brain atrophy.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
52. GLASS-MARMOR L , Paperna T, Galboiz Y, Miller A, et al
    Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. IMRELL K , Greiner E, Hillert J, Masterman T, et al
    HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
54. GORIS A , Dobosi R, Boonen S, Nagels G, et al
    KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. THESSEN HEDREUL M , Gillett A, Olsson T, Jagodic M, et al
    Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
56. ZIVADINOV R , Weinstock-Guttman B, Zorzon M, Uxa L, et al
    Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. PIGARD N , Elovaara I, Kuusisto H, Paalavuo R, et al
    Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. MASSA J , Munger KL, O'Reilly EJ, Levin LI, et al
    Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. LOSONCZI E , Bencsik K, Nagy ZF, Honti V, et al
    Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. BONETTI A , Koivisto K, Pirttila T, Elovaara I, et al
    A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
61. SMOLDERS J , Damoiseaux J, Menheere P, Tervaert JW, et al
    Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. KRYSTYNA MS , Jacek T, Sebastian R, Ewa B, et al
    Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. DUJMOVIC I , Mangano K, Pekmezovic T, Quattrocchi C, et al
    The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. HUANG YC , Lyu RK, Tseng MY, Chang HS, et al
    Decreased intrathecal synthesis of prostaglandin D2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy.
    J Neuroimmunol. 2009;206.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. SULONEN AM , Kallio SP, Ellonen P, Suvela M, et al
    No evidence for shared etiology in two demyelinative disorders, MS and PLOSL.
    J Neuroimmunol. 2009;206.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
66. HOUFF SA , Berger J, Major EO
    Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
    J Neuroimmunol. 2008;204.
    PubMed     Text format     Related articles   
    
    
    October 2008
67. RINTA S , Kuusisto H, Raunio M, Paalavuo R, et al
    Apoptosis-related molecules in blood in multiple sclerosis.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. ZEIS T , Kinter J, Herrero-Herranz E, Weissert R, et al
    Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. WEINSTOCK-GUTTMAN B , Bhasi K, Badgett D, Tamano-Blanco M, et al
    Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. FRISULLO G , Nociti V, Iorio R, Patanella AK, et al
    The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. STERNBERG Z , Chadha K, Lieberman A, Hojnacki D, et al
    Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. BENESOVA Y , Vasku A, Stourac P, Hladikova M, et al
    Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. ARISTIMUNO C , Navarro J, de Andres C, Martinez-Gines MA, et al
    Expansion of regulatory CD8(+) T-lymphocytes and fall of activated CD8(+) T-lymphocytes after iv methyl-prednisolone for multiple sclerosis relapse.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
74. HAMZAOUI K , Houman H, Hentati F, Hamzaoui A, et al
    BAFF is up-regulated in central nervous system of neuro-Behcet's disease.
    J Neuroimmunol. 2008;200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. FRANCIOTTA D , Columba-Cabezas S, Andreoni L, Ravaglia S, et al
    Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases.
    J Neuroimmunol. 2008;200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BENNETT JL , Haubold K, Ritchie AM, Edwards SJ, et al
    CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome.
    J Neuroimmunol. 2008;199.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. ALTUNTAS CZ , Daneshgari F, Liu G, Fabiyi A, et al
    Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. PALACIOS R , Comas D, Elorza J, Villoslada P, et al
    Genomic regulation of CTLA4 and Multiple Sclerosis.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. MOORE CS , Hebb AL, Blanchard MM, Crocker CE, et al
    Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. BRENNER T , Nizri E, Irony-Tur-Sinai M, Hamra-Amitay Y, et al
    Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. KARPUS WJ , Reynolds N, Behanna HA, Van Eldik LJ, et al
    Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
82. RAMAGOPALAN SV , Cukjati M, Cernilec M, Deluca GC, et al
    Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. HAMPTON DW , Anderson J, Pryce G, Irvine KA, et al
    An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. WESTALL FC
    A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis"
    J Neuroimmunol. 2008.
    PubMed     Text format     Related articles   
    
    
    
85. RAMAGOPALAN SV , Deluca GC, Degenhardt A, Ebers GC, et al
    The genetics of clinical outcome in multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. HOUFF SA , Berger J, Major EO
    Response to Linderg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles   
    
    
    
87. VYSHKINA T , Sylvester A, Sadiq S, Bonilla E, et al
    CCL genes in multiple sclerosis and systemic lupus erythematosus.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
88. MAZZANTI B , Aldinucci A, Biagioli T, Barilaro A, et al
    Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. LALIVE PH , Kantengwa S, Benkhoucha M, Juillard C, et al
    Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. RUGGIERI M , Pica C, Lia A, Zimatore GB, et al
    Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. LORENTZEN AR , Smestad C, Lie BA, Oturai AB, et al
    The SH2D2A gene and susceptibility to multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. VAN WIJMEERSCH B , Sprangers B, Dubois B, Waer M, et al
    Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: Perspective on mechanisms of action.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. VERCELLINO M , Votta B, Condello C, Piacentino C, et al
    Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
94. HAYAKAWA S , Mori M, Okuta A, Kamegawa A, et al
    Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    J Neuroimmunol. 2008;196.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SERANA F , Sottini A, Ghidini C, Zanotti C, et al
    Modulation of IFNAR1 mRNA expression in multiple sclerosis patients.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. SOTGIU S , Musumeci S, Marconi S, Gini B, et al
    Different content of chitin-like polysaccharides in multiple sclerosis and Alzheimer's disease brains.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
97. RAMAGOPALAN SV , Dyment DA, Herrera BM, Deluca GC, et al
    Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. GRABER JJ , Allie SR, Mullen KM, Jones MV, et al
    Interleukin-17 in transverse myelitis and multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. VAKNIN-DEMBINSKY A , Murugaiyan G, Hafler DA, Astier AL, et al
    Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. MALMESTROM C , Lycke J, Haghighi S, Andersen O, et al
     Relapses in multiple sclerosis are associated with increased CD8(+) T-cell mediated cytotoxicity in CSF.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
101. PAMPLIEGA O , Domercq M, Villoslada P, Sepulcre J, et al
     Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. WRAY BN , Stankovich J, Whittock L, Dwyer T, et al
     CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. COUTURIER N , Zappulla JP, Lauwers-Cances V, Uro-Coste E, et al
     Mast cell transcripts are increased within and outside multiple sclerosis lesions.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. AZOULAY D , Urshansky N, Karni A
     Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. VAKNIN-DEMBINSKY A , Brass S, Gandhi R, Weiner HL, et al
     Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS.
     J Neuroimmunol. 2008;195.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. YAMAGUCHI KD , Ruderman DL, Croze E, Wagner TC, et al
     IFN-beta-regulated genes show abnormal expression in therapy-naive relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions.
     J Neuroimmunol. 2008;195.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
107. MATESANZ F , Fernandez O, Milne RL, Fedetz M, et al
     The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. KAWANOKUCHI J , Shimizu K, Nitta A, Yamada K, et al
     Production and functions of IL-17 in microglia.
     J Neuroimmunol. 2008;194.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. MEUTH SG , Simon OJ, Grimm A, Melzer N, et al
     CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing.
     J Neuroimmunol. 2008;194.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. POULOPOULOU C , Hatzimanolis A
     Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
     J Neuroimmunol. 2008;194.
     PubMed     Text format     Related articles   
     
     
     January 2008
111. CORREALE J , Villa A
     Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. KREMLEV SG , Gaurnier-Hausser AL, Del Valle L, Perez-Liz G, et al
     Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. LINDBERG RL , Achtnichts L, Hoffmann F, Kuhle J, et al
     Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. SMOLDERS J , Damoiseaux J, Menheere P, Hupperts R, et al
     Vitamin D as an immune modulator in multiple sclerosis, a review.
     J Neuroimmunol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. MILWARD E , Kim KJ, Szklarczyk A, Nguyen T, et al
     Cleavage of myelin associated glycoprotein by matrix metalloproteinases.
     J Neuroimmunol. 2008;193.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2007
116. O'CONNOR RA , Anderton SM
     Foxp3(+) regulatory T cells in the control of experimental CNS autoimmune disease.
     J Neuroimmunol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. GILLI F , Marnetto F, Caldano M, Valentino P, et al
     Anti-interferon-beta neutralising activity is not entirely mediated by antibodies.
     J Neuroimmunol. 2007;192.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2007
118. SATTLER MB , Togni M, Gadjanski I, Suhs KW, et al
     Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis.
     J Neuroimmunol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. PACHNER AR
     Measurement of binding anti-IFNbeta antibodies in IFNbeta-treated MS patients: Lessons for the clinician and basic scientist.
     J Neuroimmunol. 2007;.
     PubMed     Text format     Related articles   
     
     
     
120. WILLENBORG DO , Staykova M
     Reglation of neuroinflammation.
     J Neuroimmunol. 2007;191.
     PubMed     Text format     Related articles   
     
     
     
121. WEISS HA , Millward JM, Owens T
     CD8+ T cells in inflammatory demyelinating disease.
     J Neuroimmunol. 2007;191.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. SEGAL BM
     The role of natural killer cells in curbing neuroinflammation.
     J Neuroimmunol. 2007;191.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2007
123. PENDER MP
     Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
     J Neuroimmunol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2007
124. BYNOE MS , Bonorino P, Viret C
     Control of experimental autoimmune encephalomyelitis by CD4(+) suppressor T cells: Peripheral versus in situ immunoregulation.
     J Neuroimmunol. 2007;.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: